Denmark, Iceland and Norway have temporarily paused the distribution of COVID-19 AstraZeneca as a precautionary measure in response to reports of blood clots following immunisation (including 1 death in Denmark). The European Medicines Agency’s safety committee is conducting a rapid review into the events.

The Therapeutic Goods Administration (TGA) have advised that a link has not been confirmed and to date there have been no reports of similar events in Australia. Extensive international vaccination programs have not indicated an increased risk of blood clots associated with the vaccine.

Vaccination with COVID-19 AstraZeneca continues in other countries including the United Kingdom and France.

Please refer to the full alert below for more information:

TGA:阿斯利康 ChAdOx1-S COVID-19 疫苗